GB0124022D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0124022D0
GB0124022D0 GBGB0124022.5A GB0124022A GB0124022D0 GB 0124022 D0 GB0124022 D0 GB 0124022D0 GB 0124022 A GB0124022 A GB 0124022A GB 0124022 D0 GB0124022 D0 GB 0124022D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0124022.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0124022.5A priority Critical patent/GB0124022D0/en
Publication of GB0124022D0 publication Critical patent/GB0124022D0/en
Priority to EP02762572A priority patent/EP1432440A2/en
Priority to PCT/GB2002/004365 priority patent/WO2003030935A2/en
Priority to CA002462582A priority patent/CA2462582A1/en
Priority to JP2003533966A priority patent/JP2005510478A/ja
Priority to US10/491,843 priority patent/US20050054726A1/en
Priority to AU2002327959A priority patent/AU2002327959A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0124022.5A 2001-10-05 2001-10-05 Novel compounds Ceased GB0124022D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0124022.5A GB0124022D0 (en) 2001-10-05 2001-10-05 Novel compounds
EP02762572A EP1432440A2 (en) 2001-10-05 2002-09-26 Adjuvants for nucleic acid vaccines
PCT/GB2002/004365 WO2003030935A2 (en) 2001-10-05 2002-09-26 Adjuvants for nucleic acid vaccines
CA002462582A CA2462582A1 (en) 2001-10-05 2002-09-26 Adjuvants for nucleic acid vaccines
JP2003533966A JP2005510478A (ja) 2001-10-05 2002-09-26 ワクチン
US10/491,843 US20050054726A1 (en) 2001-10-05 2002-09-26 Vaccine
AU2002327959A AU2002327959A1 (en) 2001-10-05 2002-09-26 Adjuvants for nucleic acid vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124022.5A GB0124022D0 (en) 2001-10-05 2001-10-05 Novel compounds

Publications (1)

Publication Number Publication Date
GB0124022D0 true GB0124022D0 (en) 2001-11-28

Family

ID=9923350

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0124022.5A Ceased GB0124022D0 (en) 2001-10-05 2001-10-05 Novel compounds

Country Status (7)

Country Link
US (1) US20050054726A1 (https=)
EP (1) EP1432440A2 (https=)
JP (1) JP2005510478A (https=)
AU (1) AU2002327959A1 (https=)
CA (1) CA2462582A1 (https=)
GB (1) GB0124022D0 (https=)
WO (1) WO2003030935A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
US7796173B2 (en) * 2003-08-13 2010-09-14 Lettvin Jonathan D Imaging system
US20120056006A1 (en) * 2010-09-03 2012-03-08 David Bendah Global warming letter
AU2015323944B2 (en) * 2014-10-01 2018-11-29 Inovio Pharmaceuticals, Inc. Vaccines having an antigen and interleukin-21 as an adjuvant
GB201512635D0 (en) * 2015-07-17 2015-08-26 Ucl Business Plc Uses of therapeutic compounds
US20260083844A1 (en) * 2022-09-15 2026-03-26 H. Lee Moffitt Cancer Center And Research Institute Inc. Downregulating inos to increase car-t killing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060008448A1 (en) * 1996-06-11 2006-01-12 Minzhen Xu Inhibition of li expression in mammalian cells
US6375944B1 (en) * 1998-09-25 2002-04-23 The Wistar Institute Of Anatomy And Biology Methods and compositions for enhancing the immunostimulatory effect of interleukin-12

Also Published As

Publication number Publication date
WO2003030935A3 (en) 2003-08-14
AU2002327959A1 (en) 2003-04-22
WO2003030935A2 (en) 2003-04-17
CA2462582A1 (en) 2003-04-17
US20050054726A1 (en) 2005-03-10
JP2005510478A (ja) 2005-04-21
EP1432440A2 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0124022D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0102578D0 (en) Novel Compounds
GB0106157D0 (en) Novel compounds
GB0100185D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0101334D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0102469D0 (en) Novel compounds
GB0100178D0 (en) Novel compounds
GB0102570D0 (en) Novel Compounds
GB0102571D0 (en) Novel Compounds
GB0102575D0 (en) Novel Compounds
GB0106584D0 (en) Novel compounds
GB0102576D0 (en) Novel compounds
GB0102577D0 (en) Novel Compounds
GB0100179D0 (en) Novel compounds
GB0103175D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)